Citations (101)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Tram Tran & Khary K. Rigg. (2023) Substance use among methadone patients in Vietnam: a systematic review. Journal of Substance Use 0:0, pages 1-11.
Read now
Read now
Tanya C. Saraiya, Martina Pavlicova, Mei-Chen Hu, Edward V. Nunes, Denise A. Hien & Aimee N. C. Campbell. (2020) Exploring gender differences among treatment-seekers who use opioids versus alcohol and other drugs. Women & Health 60:7, pages 821-838.
Read now
Read now
Lillian MacNeill, Caroline Brunelle, Enrico DiTommaso & Brittany Skelding. (2020) Client characteristics and substance use patterns in different models of methadone maintenance therapy (MMT). Journal of Substance Use 25:4, pages 377-381.
Read now
Read now
Lisa Andersson & Björn Johnson. (2020) Patient choice as a means of empowerment in opioid substitution treatment: a case from Sweden. Drugs: Education, Prevention and Policy 27:2, pages 105-117.
Read now
Read now
David Potik, Yali Abramsohn, Shaul Schreiber, Miriam Adelson & Einat Peles. (2020) Drug Abuse and Behavioral Transgressions during Methadone Maintenance Treatment (MMT) are Related to High Psychopathy Levels. Substance Use & Misuse 55:3, pages 460-468.
Read now
Read now
Steven L. Proctor, Philip L. Herschman, Ronnie Lee & Albert M. Kopak. (2019) The Role of Patient Payment Method in Premature Discharge from Methadone Maintenance Treatment. Substance Use & Misuse 54:1, pages 97-105.
Read now
Read now
Anders Håkansson & Virginia Jesionowska. (2018) Associations between substance use and type of crime in prisoners with substance use problems – a focus on violence and fatal violence. Substance Abuse and Rehabilitation 9, pages 1-9.
Read now
Read now
Mei Yang, Shu-Cai Huang, Yan-Hui Liao, Yi-Ming Deng, Hai-Yan Run, Ping-Liang Liu, Xiong-Wen Liu, Tie-Bang Liu, Shui-Yuan Xiao & Wei Hao. (2018) Clinical characteristics of poly-drug abuse among heroin dependents and association with other psychopathology in compulsory isolation treatment settings in China. International Journal of Psychiatry in Clinical Practice 22:2, pages 129-135.
Read now
Read now
Tea Rosic, Leen Naji, Monica Bawor, Brittany B Dennis, Carolyn Plater, David C Marsh, Lehana Thabane & Zainab Samaan. (2017) The impact of comorbid psychiatric disorders on methadone maintenance treatment in opioid use disorder: a prospective cohort study. Neuropsychiatric Disease and Treatment 13, pages 1399-1408.
Read now
Read now
John J. Mariani, Robert J. Malcolm, Agnieszka K. Mamczur, Jean C. Choi, Ronald Brady, Edward Nunes & Frances R. Levin. (2016) Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. The American Journal of Drug and Alcohol Abuse 42:3, pages 333-340.
Read now
Read now
Ozietta D. Taylor. (2015) Poly Substance Use in Methadone Maintenance Therapy (MMT) Patients. Journal of Human Behavior in the Social Environment 25:8, pages 822-829.
Read now
Read now
Einat Peles, Anat Sason, Oren Tene, Yoav Domany, Shaul Schreiber & Miriam Adelson. (2015) Ten Years of Abstinence in Former Opiate Addicts: Medication-Free Non-Patients Compared to Methadone Maintenance Patients. Journal of Addictive Diseases 34:4, pages 284-295.
Read now
Read now
William L. White, Michael D. Campbell, Robert D. Spencer, Howard A. Hoffman, Brian Crissman & Robert L. DuPont. (2014) Patterns of Abstinence or Continued Drug Use Among Methadone Maintenance Patients and Their Relation to Treatment Retention. Journal of Psychoactive Drugs 46:2, pages 114-122.
Read now
Read now
Paul Duffy & Adam John Mackridge. (2014) Use and diversion of illicit methadone – under what circumstances does it occur, and potential risks associated with continued use of other substances. Journal of Substance Use 19:1-2, pages 48-55.
Read now
Read now
Ingo Schäfer, Malte Fischer, Jens Reimer, Anne Karow & Christian Haasen. (2011) Significance of psychiatric comorbidity for the outcome of maintenance treatment – a review of the literature. Mental Health and Substance Use 4:1, pages 62-71.
Read now
Read now
Articles from other publishers (86)
Felipe Castillo, Mei-Chen Hu, Ying Liu, Raymond R. Balise, Roger D. Weiss, John Rotrosen, Edward V. Nunes, Andrew J. Saxon, Daniel J. Feaster & Sean X. Luo. (2023) Risks of returning to opioid use at treatment entry and early in opioid use disorder treatment: Role of non-opioid substances. Drug and Alcohol Dependence 251, pages 110926.
Crossref
Crossref
Alina Cernasev, Kenneth Hohmeier, Craig Field, Adam J. Gordon, Stacy Elliott, Kristi Carlston, Grace Broussard & Gerald Cochran. (2023) Co-use of Opioid Medications and Alcohol Prevention Study (COAPS). Substance Abuse.
Crossref
Crossref
Jennifer Lorvick, Jordana Hemberg, Madeleine J George, Joy Piontak & Megan L Comfort. (2023) Understanding polysubstance use at the daily and event levels: protocol for a mixed-methods qualitative and ecological momentary assessment study in a community-based sample of people who use illicit drugs in Oakland, California, USA. BMJ Open 13:9, pages e075380.
Crossref
Crossref
Katja Troberg, Martin Bråbäck, Pernilla Isendahl, Suzan Nilsson, Disa Dahlman & Anders Håkansson. (2023) Malmö Treatment Referral and Intervention Study (MATRIS)—36-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment—The role of stimulant use at baseline. Journal of Substance Use and Addiction Treatment 151, pages 209036.
Crossref
Crossref
Abigail Silva, Bárbara Costa, Irene Castro, Joana Mourão & Nuno Vale. (2023) New Perspective for Drug–Drug Interaction in Perioperative Period. Journal of Clinical Medicine 12:14, pages 4810.
Crossref
Crossref
Maximilian Meyer, Ferdinand Gygli, Jean N. Westenberg, Otto Schmid, Johannes Strasser, Undine E. Lang, Kenneth M. Dürsteler & Marc Vogel. (2023) Benzodiazepine use, quality of life and psychiatric symptom burden in oral and injectable opioid agonist treatment: a cross-sectional study. Addiction Science & Clinical Practice 18:1.
Crossref
Crossref
Jonatan Walde, Lisa Andersson, Björn Johnson & Anders Håkansson. (2023) Drug prescriptions preceding opioid-related deaths–a register study in forensic autopsy patients. PLOS ONE 18:5, pages e0285583.
Crossref
Crossref
Madelyn J. McDonald, Angela M. DeVeaugh-Geiss, Howard D. Chilcoat & Jennifer R. Havens. (2023) Assessing Motivations for Nonprescribed Buprenorphine Use Among Rural Appalachian Substance Users. Journal of Addiction Medicine 17:1, pages 95-100.
Crossref
Crossref
Icro Maremmani, Matteo Pacini & Angelo G. I. MaremmaniIcro Maremmani, Matteo Pacini & Angelo G. I. Maremmani. 2023. Dual Disorder Heroin Addicts. Dual Disorder Heroin Addicts
91
108
.
Lais F. Berro, C. Austin Zamarripa & James K. Rowlett. (2022) Self-Administration of Fentanyl-Alprazolam Combinations by Rhesus Monkeys Responding under a Progressive-Ratio Schedule. Journal of Pharmacology and Experimental Therapeutics 383:3, pages 199-207.
Crossref
Crossref
Kenneth L. Morford, Jeanette M. Tetrault, Bin Zhou, Fangyong Li, Brynna Gleeson, E. Jennifer Edelman, Michael D. Stein, Declan T. Barry & Lynn Madden. (2022) The impact of benzodiazepine exposure on treatment retention in an open-access methadone program: A retrospective cohort study. Drug and Alcohol Dependence 241, pages 109707.
Crossref
Crossref
Kristen A Morin, John R Dabous, Frank Vojtesek & David Marsh. (2022) Evaluating the association between urine drug screening frequency and retention in opioid agonist treatment in Ontario, Canada: a retrospective cohort study. BMJ Open 12:10, pages e060857.
Crossref
Crossref
Lisa Andersson. (2022) A transition of power in opioid substitution treatment: Clinic managers' views on the consequences of a patient choice reform. Nordic Studies on Alcohol and Drugs 39:3, pages 279-300.
Crossref
Crossref
Gerald Cochran, Elizabeth Charron, Jennifer L. Brown, Alina Cernasev, Kenneth C. Hohmeier & T. John Winhusen. (2022) Risky alcohol use among patients dispensed opioid medications: A clinical community pharmacy study. Drug and Alcohol Dependence 234, pages 109406.
Crossref
Crossref
Martin Bråbäck, Anna Brantefors, Johan Franck, Louise Brådvik, Pernilla Isendahl, Suzan Nilsson, Katja Troberg & Anders Håkansson. (2022) Substance Use, Hospitalizations, and Co-Occurring Disorders among Patients Transferred from a Needle Exchange Program to Opioid Maintenance Treatment. International Journal of Environmental Research and Public Health 19:2, pages 697.
Crossref
Crossref
Ju Nyeong Park, Kristin E. Schneider, David Fowler, Susan G. Sherman, Ramin Mojtabai & Paul S. Nestadt. (2022) Polysubstance Overdose Deaths in the Fentanyl Era: A Latent Class Analysis. Journal of Addiction Medicine 16:1, pages 49-55.
Crossref
Crossref
Michael Soyka. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
494
509
.
Kristen A. Morin, Frank Vojtesek, Shreedhar Acharya & David C. Marsh. (2021) Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada. Frontiers in Psychiatry 12.
Crossref
Crossref
Penghui Cao, Zhaohua Zhang, Jun Zhong, Shichao Xu, Qiaofang Huang & Ni Fan. (2021) Effects of treatment status and life quality on anxiety in MMT patients. Substance Abuse Treatment, Prevention, and Policy 16:1.
Crossref
Crossref
Vivian Y. O. Au, Tea Rosic, Nitika Sanger, Alannah Hillmer, Caroul Chawar, Andrew Worster, David C. Marsh, Lehana Thabane & Zainab Samaan. (2021) Factors associated with opioid overdose during medication-assisted treatment: How can we identify individuals at risk?. Harm Reduction Journal 18:1.
Crossref
Crossref
Julian Cheron & Alban de Kerchove d’Exaerde. (2021) Drug addiction: from bench to bedside. Translational Psychiatry 11:1.
Crossref
Crossref
Michael Soyka. (2021) Missbrauch und Abhängigkeit von Benzodiazepinen und Z-Drugs. Nervenheilkunde 40:08, pages 636-647.
Crossref
Crossref
Emily Loscalzo, Alexander Levit, Robert C. Sterling & Stephen P. Weinstein. (2020) Pay for Performance and Treatment Outcome in Agonist Treatment for Opioid Use Disorder. The American Journal on Addictions 30:2, pages 173-178.
Crossref
Crossref
Jørn Henrik Vold, Svetlana Skurtveit, Christer Aas, Fatemeh Chalabianloo, Pia Synnøve Kloster, Kjell Arne Johansson & Lars Thore Fadnes. (2020) Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017. BMC Health Services Research 20:1.
Crossref
Crossref
Jørn Henrik Vold, Christer Aas, Svetlana Skurtveit, Ingvild Odsbu, Fatemeh Chalabianloo, Johan Reutfors, Anne Halmøy, Kjell Arne Johansson & Lars Thore Fadnes. (2020) Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017. BMJ Open 10:8, pages e036860.
Crossref
Crossref
Aisling Máire O’Connor, Gráinne Cousins, Louise Durand, Joe Barry & Fiona Boland. (2020) Retention of patients in opioid substitution treatment: A systematic review. PLOS ONE 15:5, pages e0232086.
Crossref
Crossref
Geoffrey Maina, Hira Tahir, Angelica Docabo, Nyambura Kahia & Caroline Brunelle. (2019) Exploring health-care providers’ experiences in the care of clients on opioid agonist treatment in two western Canadian clinics. Canadian Journal of Nursing Research 52:1, pages 15-24.
Crossref
Crossref
Courtney T Blondino, Mirinda Ann Gormley, DaShaunda D H Taylor, Elizabeth Lowery, James S Clifford, Benjamin Burkart, Whitney C Graves, Juan Lu & Elizabeth C Prom-Wormley. (2020) The Influence of Co-Occurring Substance Use on the Effectiveness of Opiate Treatment Programs According to Intervention Type. Epidemiologic Reviews 42:1, pages 57-78.
Crossref
Crossref
Zeynab Heydari, Mohammad Reza Baneshi, Hamid Sharifi, Maryam Zamanian, Saiedeh Haji-Maghsoudi & Farzaneh Zolala. (2019) Evaluation of the treatment failure ratio in individuals receiving methadone maintenance therapy via the network scale up method. International Journal of Drug Policy 73, pages 36-41.
Crossref
Crossref
I.T. Mahu, P.J. Conrod, S.P. Barrett, A. Sako, J. Swansburg, M. Lawrence, F. Laroque, J.F. Morin, A. Chinneck, R. Nogueira-Arjona & S.H. Stewart. (2019) Specificity of personality relationships to particular forms of concurrent substance use among methadone maintenance therapy clients. Addictive Behaviors 98, pages 106056.
Crossref
Crossref
Joshua A. Barocas, Jianing Wang, Brandon D.L. Marshall, Marc R. LaRochelle, Amy Bettano, Dana Bernson, Curt G. Beckwith, Benjamin P. Linas & Alexander Y. Walley. (2019) Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug and Alcohol Dependence 200, pages 59-63.
Crossref
Crossref
Victoria R. Votaw, Rachel Geyer, Maya M. Rieselbach & R. Kathryn McHugh. (2019) The epidemiology of benzodiazepine misuse: A systematic review. Drug and Alcohol Dependence 200, pages 95-114.
Crossref
Crossref
Joseph K. Eibl, Andrew S. Wilton, Alexandra M. Franklyn, Paul Kurdyak & David C. Marsh. (2019) Evaluating the Impact of Prescribed Versus Nonprescribed Benzodiazepine Use in Methadone Maintenance Therapy: Results From a Population-based Retrospective Cohort Study. Journal of Addiction Medicine 13:3, pages 182-187.
Crossref
Crossref
Shannon R. Kenney, Bradley J. Anderson, Genie L. Bailey & Michael D. Stein. (2018) Expectations about alcohol, cocaine, and benzodiazepine abstinence following inpatient heroin withdrawal management. The American Journal on Addictions 28:1, pages 36-42.
Crossref
Crossref
Victoria R. Votaw, Katie Witkiewitz, Linda Valeri, Olivera Bogunovic & R. Kathryn McHugh. (2019) Nonmedical prescription sedative/tranquilizer use in alcohol and opioid use disorders. Addictive Behaviors 88, pages 48-55.
Crossref
Crossref
Jennifer Lorvick, Erica N. Browne, Barrot H. Lambdin & Megan Comfort. (2018) Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine. Addictive Behaviors 85, pages 94-99.
Crossref
Crossref
Gerald CochranWei-Hsuan Lo-CiganicWalid F. GelladAdam J. GordonEvan ColeCarroline LoboWinfred FrazierPing ZhengChung-Chou H. ChangDavid KelleyJulie M. Donohue. (2018) Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees. Journal of Managed Care & Specialty Pharmacy 24:9, pages 875-885.
Crossref
Crossref
Élise Roy, Nelson Arruda, Didier Jutras-Aswad, Djamal Berbiche, Rossio Motta-Ochoa & Julie Bruneau. (2018) Tranquilizer misuse among active cocaine users: Predictors of initiation. Drug and Alcohol Review 37:4, pages 520-526.
Crossref
Crossref
Matthew E. Hirschtritt, Kevin L. Delucchi & Mark Olfson. (2018) Outpatient, combined use of opioid and benzodiazepine medications in the United States, 1993–2014. Preventive Medicine Reports 9, pages 49-54.
Crossref
Crossref
Alexandra M. Franklyn, Joseph K. Eibl, Graham Gauthier, David Pellegrini, Nancy E. Lightfoot & David C. Marsh. (2017) The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario. Harm Reduction Journal 14:1.
Crossref
Crossref
Alexandra M. Franklyn, Joseph K. Eibl, Graham J. Gauthier & David C. Marsh. (2017) The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada. PLOS ONE 12:11, pages e0187633.
Crossref
Crossref
Alexandra M. Franklyn, Joseph K. Eibl, Graham J. Gauthier, David Pellegrini, Nancy E. Lightfoot & David C. Marsh. (2017) The impact of cocaine use in patients enrolled in opioid agonist therapy in Ontario, Canada. International Journal of Drug Policy 48, pages 1-8.
Crossref
Crossref
Gerald Cochran, Rebecca McCarthy, Adam J. Gordon & Ralph E. Tarter. (2017) Opioid medication misuse among unhealthy drinkers. Drug and Alcohol Dependence 179, pages 13-17.
Crossref
Crossref
Michael D. Stein, Bradley J. Anderson, Shannon R. Kenney & Genie L. Bailey. (2017) Beliefs about the consequences of using benzodiazepines among persons with opioid use disorder. Journal of Substance Abuse Treatment 77, pages 67-71.
Crossref
Crossref
Marcus Herdener, Kenneth M Dürsteler, Erich Seifritz & Carlos Nordt. (2017) Changes in substance use in patients receiving opioid substitution therapy and resulting clinical challenges: a 17-year treatment case register analysis. The Lancet Psychiatry 4:4, pages 302-309.
Crossref
Crossref
Stefano Tamburin, Angela Federico, Marco Faccini, Rebecca Casari, Laura Morbioli, Valentina Sartore, Antonio Mirijello, Giovanni Addolorato & Fabio Lugoboni. (2017) Determinants of Quality of Life in High-Dose Benzodiazepine Misusers. International Journal of Environmental Research and Public Health 14:1, pages 38.
Crossref
Crossref
Adam Bakker & Emmanuel Streel. (2016) Benzodiazepine maintenance in opiate substitution treatment: Good or bad? A retrospective primary care case-note review. Journal of Psychopharmacology 31:1, pages 62-66.
Crossref
Crossref
Rachel M. Deacon, Suzanne Nielsen, Stefanie Leung, Gonzalo Rivas, Tim Cubitt, Lauren A. Monds, Nadine Ezard, Briony Larance & Nicholas Lintzeris. (2016) Alprazolam use and related harm among opioid substitution treatment clients – 12 months follow up after regulatory rescheduling. International Journal of Drug Policy 36, pages 104-111.
Crossref
Crossref
Michael D. Stein, Mitika Kanabar, Bradley J. Anderson, Anna Lembke & Genie L. Bailey. (2016) Reasons for Benzodiazepine Use Among Persons Seeking Opioid Detoxification. Journal of Substance Abuse Treatment 68, pages 57-61.
Crossref
Crossref
Amy Peacock, Raimondo Bruno, Briony Larance, Nick Lintzeris, Suzanne Nielsen, Robert Ali, Timothy Dobbins & Louisa Degenhardt. (2016) Same-day use of opioids and other central nervous system depressants amongst people who tamper with pharmaceutical opioids: A retrospective 7-day diary study. Drug and Alcohol Dependence 166, pages 125-133.
Crossref
Crossref
Yoko Murphy, Emily Wilson, Elliot M. Goldner & Benedikt Fischer. (2016) Benzodiazepine Use, Misuse, and Harm at the Population Level in Canada: A Comprehensive Narrative Review of Data and Developments Since 1995. Clinical Drug Investigation 36:7, pages 519-530.
Crossref
Crossref
Paxton BachGeoffrey WaltonKanna HayashiM-J MilloyHuiru DongThomas KerrJulio MontanerEvan Wood. (2016) Benzodiazepine Use and Hepatitis C Seroconversion in a Cohort of Persons Who Inject Drugs. American Journal of Public Health 106:6, pages 1067-1072.
Crossref
Crossref
Shane Darke & Michael Farrell. (2016) Which medications are suitable for agonist drug maintenance?. Addiction 111:5, pages 767-774.
Crossref
Crossref
James M. Schuster, David Loveland, Meghna Parthasarathy, Nicole Maiolo, Alyssa Cilia & Kim Castelnovo. (2016) Reducing Problematic Benzodiazepine Use Among Individuals Enrolled in Methadone Treatment Programs. Journal of Addiction Medicine 10:3, pages 202-207.
Crossref
Crossref
Disa Dahlman, Tove Abrahamsson, Alex H. Kral & Anders Hakansson. (2016) Nonmedical Use of Antihistaminergic Anxiolytics and Other Prescription Drugs among Persons with Opioid Dependence. Journal of Addiction 2016, pages 1-11.
Crossref
Crossref
Perrine Roux, Caroline Lions, Laurent Michel, Antoine Vilotitch, Marion Mora, Gwenaelle Maradan, Fabienne Marcellin, Bruno Spire, Morel Alain & Carrieri M. Patrizia. (2016) Concomitant use of benzodiazepine and alcohol in methadone-maintained patients from the ANRS-Methaville trial: Preventing the risk of opioid overdose in patients who failed with buprenorphine. Drug and Alcohol Review 35:1, pages 61-69.
Crossref
Crossref
Татјана Петрушевска. (2015) Употреба на бензодијазепини кај пациенти на метадонски третман. Macedonian Medical Electronic Journal 1:1, pages 1-262.
Crossref
Crossref
Aishwarya Vijay, Alexander R. Bazazi, Ilias Yee, Adeeba Kamarulzaman & Frederick L. Altice. (2015) Treatment Readiness, Attitudes Toward, and Experiences with Methadone and Buprenorphine Maintenance Therapy Among People Who Inject Drugs in Malaysia. Journal of Substance Abuse Treatment 54, pages 29-36.
Crossref
Crossref
David Fernández-Calderón, Fermín Fernández, Sofía Ruiz-Curado, Antonio Verdejo-García & Óscar M. Lozano. (2015) Profiles of substance use disorders in patients of therapeutic communities: Link to social, medical and psychiatric characteristics. Drug and Alcohol Dependence 149, pages 31-39.
Crossref
Crossref
Erin Stevenson & Jennifer Cole. (2015) Associations between chronic non‐cancer pain and medication assisted treatment outcomes for opiate addiction. The American Journal on Addictions 24:2, pages 138-143.
Crossref
Crossref
Waimar Tun, Meredith Sheehy, Dita Broz, Jerry Okal, Nicholas Muraguri, H. Fisher Raymond, Helgar Musyoki, Andrea A. Kim, Mercy Muthui & Scott Geibel. (2014) HIV and STI Prevalence and Injection Behaviors Among People Who Inject Drugs in Nairobi: Results from a 2011 Bio-behavioral Study Using Respondent-Driven Sampling. AIDS and Behavior 19:S1, pages 24-35.
Crossref
Crossref
Sanna Rönkä, Karoliina Karjalainen, Erkki Vuori & Pia Mäkelä. (2015) Personally prescribed psychoactive drugs in overdose deaths among drug abusers: A retrospective register study. Drug and Alcohol Review 34:1, pages 82-89.
Crossref
Crossref
Patrizia Maria Carrieri, Laurent Michel, Caroline Lions, Julien Cohen, Muriel Vray, Marion Mora, Fabienne Marcellin, Bruno Spire, Alain Morel & Perrine Roux. (2014) Methadone Induction in Primary Care for Opioid Dependence: A Pragmatic Randomized Trial (ANRS Methaville). PLoS ONE 9:11, pages e112328.
Crossref
Crossref
Fabio Lugoboni, Antonio Mirijello, Marco Faccini, Rebecca Casari, Anthony Cossari, Gessica Musi, Giorgia Bissoli, Gianluca Quaglio & Giovanni Addolorato. (2014) Quality of life in a cohort of high-dose benzodiazepine dependent patients. Drug and Alcohol Dependence 142, pages 105-109.
Crossref
Crossref
Tatjana Petrushevska & Vesna Velik Stefanovska. (2014) Patients on Opioid Substitution Treatment in the Republic of Macedonia: What Do Treatment Demand Data Tell Us?. Open Access Macedonian Journal of Medical Sciences 2:2, pages 335-343.
Crossref
Crossref
Chethan Bachireddy, Michael C. Soule, Jacob M. Izenberg, Sergey Dvoryak, Konstantin Dumchev & Frederick L. Altice. (2014) Integration of health services improves multiple healthcare outcomes among HIV-infected people who inject drugs in Ukraine. Drug and Alcohol Dependence 134, pages 106-114.
Crossref
Crossref
Suzanne NielsenRaimondo BrunoLouisa DegenhardtMark A StooveJane A FischerSusan J CarruthersNicholas Lintzeris. (2013) The sources of pharmaceuticals for problematic users of benzodiazepines and prescription opioids. Medical Journal of Australia 199:10, pages 696-699.
Crossref
Crossref
Zev Schuman-Olivier, Bettina B. Hoeppner, Roger D. Weiss, Jacob Borodovsky, Howard J. Shaffer & Mark J. Albanese. (2013) Benzodiazepine use during buprenorphine treatment for opioid dependence: Clinical and safety outcomes. Drug and Alcohol Dependence 132:3, pages 580-586.
Crossref
Crossref
Shelly Iskandar, Reinout van Crevel, Teddy Hidayat, Ike M.P. Siregar, Tri H. Achmad, Andre J. van der Ven & Cor A. De Jong. (2013) Severity of psychiatric and physical problems is associated with lower quality of life in methadone patients in Indonesia. The American Journal on Addictions 22:5, pages 425-431.
Crossref
Crossref
Hsin-Ya Lee, Jih-Heng Li, Yuh-Ling Sheu, Hsin-Pei Tang, Wei-Chiao Chang, Tze-Chun Tang, Yi-Chun Yeh, Shing-Yaw Wang & Ray-H. Liu. (2013) Moving toward Personalized Medicine in the Methadone Maintenance Treatment Program: A Pilot Study on the Evaluation of Treatment Responses in Taiwan. BioMed Research International 2013, pages 1-11.
Crossref
Crossref
R. Kathryn McHugh, Heather W. Murray, Bridget A. Hearon, Elizabeth M. Pratt, Mark H. Pollack, Steven A. Safren & Michael W. Otto. (2013) Predictors of Dropout from Psychosocial Treatment in Opioid‐Dependent Outpatients. The American Journal on Addictions 22:1, pages 18-22.
Crossref
Crossref
Hsin-Ya Lee, Jih-Heng Li, Li-Tzy Wu, Jin-Song Wu, Cheng-Fang Yen & Hsin-Pei Tang. (2012) Survey of methadone-drug interactions among patients of methadone maintenance treatment program in Taiwan. Substance Abuse Treatment, Prevention, and Policy 7:1.
Crossref
Crossref
Perrine Roux, Laurent Michel, Julien Cohen, Marion Mora, Alain Morel, Jean-Francois Aubertin, Jean-Claude Desenclos, Bruno Spire & Patrizia M Carrieri. (2012) Methadone induction in primary care (ANRS-Methaville): a phase III randomized intervention trial. BMC Public Health 12:1.
Crossref
Crossref
Wen-Yu Hsu, Nan-Ying Chiu, Jui-Ting Liu, Chieh-Hui Wang, Ting-Gang Chang, Yi-Cheng Liao & Pei-I Kuo. (2014) Sleep quality in heroin addicts under methadone maintenance treatment. Acta Neuropsychiatrica 24:6, pages 356-360.
Crossref
Crossref
Jermaine D. Jones, Shanthi Mogali & Sandra D. Comer. (2012) Polydrug abuse: A review of opioid and benzodiazepine combination use. Drug and Alcohol Dependence 125:1-2, pages 8-18.
Crossref
Crossref
Tunde Apantaku-Olajide, Kevin Ducray, Patricia Byrne & Bobby P. Smyth. (2018) Perception of unmet needs and association with benzodiazepine misuse among patients on a methadone maintenance treatment programme. The Psychiatrist 36:5, pages 169-174.
Crossref
Crossref
Donald G. Barceloux. 2012. Medical Toxicology of Drug Abuse. Medical Toxicology of Drug Abuse
579
602
.
Heather G Fulton, Sean P Barrett, Cindy MacIsaac & Sherry H Stewart. (2011) The relationship between self-reported substance use and psychiatric symptoms in low-threshold methadone maintenance treatment clients. Harm Reduction Journal 8:1.
Crossref
Crossref
Marc Vogel, Kenneth M. Dürsteler-MacFarland, Marc Walter, Johannes Strasser, Stephanie Fehr, Luis Prieto & Gerhard A. Wiesbeck. (2011) Prolonged use of benzodiazepines is associated with childhood trauma in opioid-maintained patients. Drug and Alcohol Dependence 119:1-2, pages 93-98.
Crossref
Crossref
Li-Tzy Wu, Walter Ling, Bruce Burchett, Dan G. Blazer, Chongming Yang, Jeng-Jong Pan, Bryce B. Reeve & George E. Woody. (2011) Use of item response theory and latent class analysis to link poly-substance use disorders with addiction severity, HIV risk, and quality of life among opioid-dependent patients in the Clinical Trials Network. Drug and Alcohol Dependence 118:2-3, pages 186-193.
Crossref
Crossref
Chethan Bachireddy, Alexander R. Bazazi, Ravi Kavasery, Sumathi Govindasamy, Adeeba Kamarulzaman & Frederick L. Altice. (2011) Attitudes toward opioid substitution therapy and pre-incarceration HIV transmission behaviors among HIV-infected prisoners in Malaysia: Implications for secondary prevention. Drug and Alcohol Dependence 116:1-3, pages 151-157.
Crossref
Crossref
Francisco José Eiroa-Orosa, Christian Haasen, Uwe Verthein, Christoph Dilg, Ingo Schäfer & Jens Reimer. (2010) Benzodiazepine use among patients in heroin-assisted vs. methadone maintenance treatment: Findings of the German randomized controlled trial. Drug and Alcohol Dependence 112:3, pages 226-233.
Crossref
Crossref
Frederick L Altice, Adeeba Kamarulzaman, Vincent V Soriano, Mauro Schechter & Gerald H Friedland. (2010) Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet 376:9738, pages 367-387.
Crossref
Crossref
Frank Barile. 2010. Clinical Toxicology. Clinical Toxicology
138
149
.
Nicholas Lintzeris & Suzanne Nielsen. (2009) Benzodiazepines, Methadone and Buprenorphine: Interactions and Clinical Management. The American Journal on Addictions 19:1, pages 59-72.
Crossref
Crossref
Katja Troberg, Martin Bråbäck, Pernilla Isendahl, Suzan Nilsson, Disa Dahlman & Anders Håkansson. (2022) Malmö Treatment Referral and Intervention Study (MATRIS)—36-Month Follow-Up on Retention and Substance Use Among Patients Referred from a Needle Exchange Program to Opioid Substitution Treatment. SSRN Electronic Journal.
Crossref
Crossref